Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06454578
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-06-06
Brief Title:
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
Sponsor:
Qilu Hospital of Shandong University
Organization:
Qilu Hospital of Shandong University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-06
First Submit QC Date:
June 6 2024
Study First Post Date:
2024-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-30
Last Update Post Date:
2024-06-12
Last Update Post Date Type:
ACTUAL